The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson

Поделиться
HTML-код
  • Опубликовано: 30 окт 2024
  • The year 2024 brings new promise in multiple myeloma with a wide variety of treatment options avaiable for both newly diagnosed and relapsed/refractory patients. Learn about the progress being made and the very latest in determining risk at diagnosis, strategies for smoldering myeloma patients, optimal treatments for newly diagnosed patients, things to consider at first relapse and beyond. Dr. Robert Orlowski will review advances in CAR T therapies, bispecific antibodies, targeted therapies and combination approaches and clinical trials to watch as the research continues advancing at a rapid pace in myeloma.
    Thanks to our episode sponsor, GSK.

Комментарии •